| Literature DB >> 30356511 |
Parisa Mansoori1,2,3, Reza Majdzadeh2,4,5,3, Zhaleh Abdi6, Igor Rudan1, Kit Yee Chan1,7,3, Mohsen Aarabi8,9, Elham Ahmadnezhad6, Shirin Ahmadnia10, Shahin Akhondzadeh11, Ali Azin12, Fereidoun Azizi13, Reza Dehnavieh14, Hassan Eini-Zinab15, Farshad Farzadfar16, Mohammad Hosein Farzaei17, Mostafa Ghanei18, AliAkbar Haghdoost19, Sedigheh Hantoushzadeh20, Gholamreza Heydari21, Hassan Joulaei22, Naser Kalantari23, Roya Kelishadi24, Ardeshir Khosravi25, Bagher Larijani26, Amir Hossein Mahvi5,27, Ali Reza Massah Bavani28, Alireza Mesdaghinia29, Azarakhsh Mokri30, Ali Montazeri31, Ehsan Mostafavi32, Seyed Abbas Motevalian33, Kazem Naddafi34,35, Shekoufeh Nikfar36, Seyed Ali Nojoumi37, Maryam Noroozian38, Alireza Olyaeemanesh6,39, Nasrin Omidvar40, Abbas Ostadtaghizadeh41, Farshad Pourmalek42, Roja Rahimi43, Afarin Rahimi-Movaghar30, Arash Rashidian44, Emran Razaghi45, Homayoun Sadeghi-Bazargani46, Gholamhosain Salehi Zalani47, Hamid Soori48, Jafar Sadegh Tabrizi49, AbouAli Vedadhir50,51, Bahareh Yazdizadeh2, Masud Yunesian52, Mehdi Zare53.
Abstract
BACKGROUND: In 2015, it was estimated that the burden of disease in Iran comprised of 19 million disability-adjusted life years (DALYs), 74% of which were due to non-communicable diseases (NCDs). The observed leading causes of death were cardiovascular diseases (41.9%), neoplasms (14.9%), and road traffic injuries (7.4%). Even so, the health research investment in Iran continues to remain limited. This study aims to identify national health research priorities in Iran for the next five years to assist the efficient use of resources towards achieving the long-term health targets.Entities:
Mesh:
Year: 2018 PMID: 30356511 PMCID: PMC6188089 DOI: 10.7189/jogh.08.020702
Source DB: PubMed Journal: J Glob Health ISSN: 2047-2978 Impact factor: 4.413
List of the included five criteria and the agreed definition for each
| Number | Criterion | Definition |
|---|---|---|
| Feasibility | (1) There is sufficient capacity (eg, data infrastructure, laboratory equipment) to carry out this research; (2) It is possible to provide training for the staff who would undertake this research; (3) This research can be conducted in an ethical way and produce informative results within the next five years | |
| Impact on health | Results of this research have high potential to improve health by: (1) reducing disease incidence and/or prevalence; (2) reducing social, environmental, and/or individual risk factors of ill-health; (3) shaping future health planning and implementation; (4) improving health services delivery by improving acceptability, accessibility, suitability, efficiency, efficacy, effectiveness, and/or safety of treatment or service; and/or (5) improving societal and system preparedness for future health challenges | |
| Impact on economy | Results of this research have high potential in: (1) having direct effect on the production of materials or consumer services; (2) optimising the earlier goods and/or products (increasing quality and/or reducing production costs); (3) creating knowledge-based entrepreneurship; (4) decreasing days of work missed due to illness or disability for patients and caregivers; (5) reducing opportunity costs for patients and caregivers; (6) reducing impact on direct patient costs as well as health and welfare systems; and/or (7) reducing caregiver burden and its associated financial costs (including health care costs for caregivers) | |
| Capacity building | Results of this research have high potential to lead to: (1) education and training in Iran's human resources; (2) the acquisition of new skills by the research team; and/or (3) investment to improve research facilities/amenities where the study will be undertaken, eg, purchasing software/equipment | |
| Equity | Results of this research have high potential to: (1) lead to interventions or services that will be accessible and affordable to everyone, including members of vulnerable groups; (2) lead to policy, plans, interventions or services that could reduce health inequality. This could be achieved by policies or interventions that target and empower vulnerable groups to reduce risk and disease exposures and/or improve access to services or interventions. |
The top 10 priorities for health research for Iran, ranked by wRPS
| Rank | Proposed RQ | wRPS | AEA | Feasibility | Impact on health | Impact on economy | Capacity building | Equity |
|---|---|---|---|---|---|---|---|---|
| How do we reform Iran's health insurance system to improve equity? | 84.5 | 68 | 81 | 91 | 91 | 63 | 91 | |
| What should be Iran's non-communicable diseases prevention strategy? How could it be integrated into primary health care? | 84.2 | 66 | 86 | 93 | 83 | 69 | 83 | |
| What are the most effective and cost-effective population-level interventions for reducing and managing non-communicable diseases (eg, ischemic heart diseases, diabetes, stroke, hypertension, and dementia) and road traffic injuries in the Iranian context? | 84.2 | 65 | 84 | 91 | 88 | 64 | 88 | |
| How do we tailor our primary qualifications (eg, Doctor of Medicine, and Doctor of Pharmacy) and higher qualifications (eg, specialist training in psychiatry) in medical and health sciences in Iran to better serve the needs of the nation? | 81.2 | 60 | 84 | 83 | 79 | 80 | 79 | |
| What are the leading non-communicable diseases (eg, diabetes, stroke, cardiovascular disease, hypertension, and cancer) in Iran now and in 2030? How are they distributed across the country and what are their underlying causes? | 79.6 | 60 | 86 | 87 | 79 | 57 | 79 | |
| To what extent are health resources and services equally distributed across the country? To what extent do they meet the needs of the people? How do we reduce inequality in health service access in Iran and achieve Universal Health Coverage? | 79.2 | 65 | 85 | 89 | 76 | 60 | 76 | |
| What is the health status and common health problems in Iran's elderly population? How will these change by the year 2030? What is the economic burden of these problems and how can we reduce this burden? | 78.6 | 58 | 87 | 89 | 74 | 58 | 74 | |
| What is the current status of antibiotic resistance in Iran and future predictions? What is the current antibiotic prescription pattern(s) of medical practitioners in Iran? What can we do to promote more rational use of antibiotics? | 78.1 | 53 | 85 | 88 | 77 | 51 | 77 | |
| What are the health impacts of Iran's water crisis? For example, how has the Lake Urmia water crisis impacted the health of residents in nearby provinces? What can the Ministry of Health and Medical Education and health centers across the country do to respond to water crises? | 78.0 | 58 | 75 | 86 | 81 | 60 | 81 | |
| How can we replace the current physician-centered system with a team-based care approach (ie, the provision of health services by at least two health professionals including medical doctors, clinical pharmacists, nurses who work collaboratively with patients, family caregivers, and community service providers to achieve care)? | 77.8 | 60 | 73 | 84 | 78 | 72 | 78 |
RQ – research question; wRPS – weighted research priority score; AEA – average expert agreement